Wealth Enhancement Advisory Services
OGN icon

Wealth Enhancement Advisory Services’s Organon & Co OGN Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$381K Sell
28,192
-16,760
-37% -$200K ﹤0.01% 2963
2026
Q1 		$286K Sell
44,952
-31,595
-41% -$238K ﹤0.01% 2826
2025
Q4 		$618K Sell
76,547
-28,880
-27% -$228K ﹤0.01% 2322
2025
Q3 		$1.12M Buy
105,427
+49,315
+88% +$484K ﹤0.01% 1779
2025
Q2 		$559K Buy
56,112
+20,507
+58% +$212K ﹤0.01% 2146
2025
Q1 		$530K Sell
35,605
-1,792
-5% -$27.6K ﹤0.01% 2020
2024
Q4 		$558K Sell
37,397
-5,463
-13% -$89K ﹤0.01% 1916
2024
Q3 		$820K Sell
42,860
-2,546
-6% -$52.8K ﹤0.01% 1506
2024
Q2 		$940K Buy
45,406
+6,737
+17% +$134K ﹤0.01% 1309
2024
Q1 		$727K Buy
38,669
+2,800
+8% +$48K ﹤0.01% 1379
2023
Q4 		$517K Buy
35,869
+6,099
+20% +$83K ﹤0.01% 1482
2023
Q3 		$517K Buy
+29,770
New +$621K ﹤0.01% 1407

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Wealth Enhancement Advisory Services's OGN Position: Q2 2026 in Review

Wealth Enhancement Advisory Services reduced its Organon & Co (OGN) stake by 37% in Q2 2026, selling an estimated $200K and leaving 28,192 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #2963.

Wealth Enhancement Advisory Services first reported a position in OGN in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.12M in Q3 2025. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Wealth Enhancement Advisory Services held 28,192 shares of Organon & Co worth $381K as of Q2 2026.
  • Wealth Enhancement Advisory Services sold 16,760 Organon & Co shares in Q2 2026, an estimated $200K.
  • Organon & Co made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2963 holding.
  • Wealth Enhancement Advisory Services first reported a position in Organon & Co in Q3 2023 and has held it in 12 quarters since.
  • Wealth Enhancement Advisory Services's Organon & Co position peaked at $1.12M in Q3 2025.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.